Abstract:Ruthenium-containing complexes have emerged as good alternative to the currently used platinum-containing drugs for malignant tumor therapy. In this work, cytotoxic effects of recently synthesized ruthenium polypyridyl complexes [Ru(bpy)2(CFPIP)](ClO4)2 (bpy = 2,2′-bipyridine, CFPIP = (E)-2-(4-fluorostyryl)-1H-imidazo[4,5-f][1,10]phenanthroline, Ru(II)-1), [Ru(phen)2(CFPIP)](ClO4)2 (phen = 1,10-phenanthroline, Ru(II)-2) and [Ru(dmb)2(CFPIP)](ClO4)2 (dmb = 4,4′-dimethyl-2,2′-bipyridine, Ru(II)-3) toward different tumor cells were investigated in vitro and compared with cisplatin, the most widely used chemotherapeutic drug against hepatocellular carcinoma (HepG-2). The results demonstrate that target complexes show excellent cytotoxicity against HepG-2 cells with low IC50 value of 21.4 ± 1.5, 18.0 ± 2.1 and 22.3 ± 1.7 μM, respectively. It was important noting that target Ru(II) complexes exhibited better antitumor activity than cisplatin (IC50 = 28.5 ± 2.4 μM) against HepG-2 cells, and has no obvious toxicity to normal cell LO2. DNA binding results suggest that Ru(II)-1, Ru(II)-2 and Ru(II)-3 interact with CT DNA (calf thymus DNA) through intercalative mode. Complexes exerted its antitumor activity through increasing anti-migration and inducing cell cycle arrest at the S phase. In addition, the apoptosis was tested by AO (acridine orange)/EB (ethidium bromide) staining and flow cytometry. Mitochondrial membrane potential (MMP), reactive oxygen species (ROS), and colocalization tests were also evaluated by ImageXpress Micro XLS system. Overall, the results show that the ruthenium polypyridyl complexes induce apoptosis in HepG-2 cells through ROS-mediated mitochondria dysfunction pathway.

Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes

Synthesis, Crystal and Electronic Structure, Anticancer Activity of Ruthenium(Ii) Arene Complexes with Thiosemicarbazones

Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.

Synthesis, Cytotoxicity and Anti‐metastatic Properties of New Pyridyl–thiazole Arene Ruthenium(ii) Complexes

Synthesis, characterization, and antitumor activity of mononuclear and dinuclear ruthenium complexes

Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes

Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Synthesis, structures, antiproliferative activity of a series of ruthenium(II) arene derivatives of thiosemicarbazones ligands

Study on antitumor activity of three ruthenium arene complexes in vitro

Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights

New Dinuclear Ruthenium Arene Complexes Containing Thiosemicarbazone Ligands: Synthesis, Structure and Cytotoxic Studies.

Synthesis, Characterization, And Anticancer Activity Of A Series Of Ketone-N-4-Substituted Thiosemicarbazones And Their Ruthenium(Ii) Arene Complexes

Synthesis, Characterization, Cellular Uptake and Apoptosis-Inducing Properties of Two Highly Cytotoxic Cyclometalated Ruthenium(ii) Β-Carboline Complexes.

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (poly)cyclic Aromatic Diamine Ligands.

Novel Dinuclear Arene Ruthenium(ii) Complexes: Synthesis, Structure, Anticancer Activity and Interaction with DNA

Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole.

Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction

Comparison Between Polypyridyl and Cyclometalated Ruthenium(Ii) Complexes: Anticancer Activities Against 2d and 3d Cancer Models

Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes

Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.

Cytotoxic Cis-Ruthenium(iii) Bis(amidine) Complexes.